{ "labelLang" : "hun", "responseDate" : "2024-03-28 22:46", "content" : { "otype" : "JournalArticle", "mtid" : 31823796, "status" : "VALIDATED", "published" : true, "comment" : "Export Date: 4 May 2021 \n CODEN: JNSCA \n Correspondence Address: Gold, M.S.; Department of Psychiatry, United States; email: drmarksgold@gmail.com", "unhandledTickets" : 0, "deleted" : false, "lastRefresh" : "2023-02-09T23:30:46.680+0000", "lastModified" : "2021-01-22T11:04:16.171+0000", "created" : "2021-01-22T11:04:11.301+0000", "creator" : { "otype" : "Author", "mtid" : 10022604, "link" : "/api/author/10022604", "label" : "Kótyuk Eszter (Pszichológia)", "familyName" : "Kótyuk", "givenName" : "Eszter", "published" : true, "oldId" : 10022604, "snippet" : true }, "lastDuplumSearch" : "2024-01-17T11:54:17.330+0000", "validated" : "2021-10-01T22:47:33.555+0000", "validator" : { "otype" : "Admin", "mtid" : 10067876, "link" : "/api/admin/10067876", "label" : "MTMT API (MTMT API user, admin)", "familyName" : "MTMT", "givenName" : "API", "published" : true, "snippet" : true }, "core" : false, "citation" : true, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 24, "link" : "/api/publicationtype/24", "label" : "Folyóiratcikk", "code" : 24, "otypeName" : "JournalArticle", "listPosition" : 1, "published" : true, "oldId" : 24, "snippet" : true }, "subType" : { "otype" : "SubType", "mtid" : 1134514, "link" : "/api/subtype/1134514", "label" : "Összefoglaló cikk (Folyóiratcikk)", "name" : "Összefoglaló cikk", "nameEng" : "Survey paper", "docType" : { "otype" : "PublicationType", "mtid" : 24, "link" : "/api/publicationtype/24", "label" : "Folyóiratcikk", "code" : 24, "otypeName" : "JournalArticle", "listPosition" : 1, "published" : true, "oldId" : 24, "snippet" : true }, "listPosition" : 102, "published" : true, "oldId" : 1134514, "snippet" : true }, "category" : { "otype" : "Category", "mtid" : 1, "link" : "/api/category/1", "label" : "Tudományos", "published" : true, "oldId" : 1, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10002, "link" : "/api/language/10002", "label" : "Angol", "name" : "Angol", "nameEng" : "English", "published" : true, "oldId" : 2, "snippet" : true } ], "firstAuthor" : "Blum, Kenneth", "authorships" : [ { "otype" : "PersonAuthorship", "mtid" : 95234861, "link" : "/api/authorship/95234861", "label" : "Blum, Kenneth", "listPosition" : 1, "share" : 0.0, "first" : true, "last" : false, "corresponding" : false, "familyName" : "Blum", "givenName" : "Kenneth", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 95234862, "link" : "/api/authorship/95234862", "label" : "Cadet, Jean Lud", "listPosition" : 2, "share" : 0.0, "first" : false, "last" : false, "corresponding" : false, "familyName" : "Cadet", "givenName" : "Jean Lud", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 95234863, "link" : "/api/authorship/95234863", "label" : "Gold, Mark S.", "listPosition" : 3, "share" : 0.0, "first" : false, "last" : true, "corresponding" : false, "familyName" : "Gold", "givenName" : "Mark S.", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true } ], "title" : "Psychostimulant use disorder emphasizing methamphetamine and the opioid -dopamine connection: Digging out of a hypodopaminergic ditch", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 18321740, "link" : "/api/publicationidentifier/18321740", "label" : "DOI: 10.1016/j.jns.2020.117252", "source" : { "otype" : "PlainSource", "mtid" : 6, "link" : "/api/publicationsource/6", "label" : "DOI", "type" : { "otype" : "PublicationSourceType", "mtid" : 10001, "link" : "/api/publicationsourcetype/10001", "label" : "DOI", "mayHaveOa" : true, "published" : true, "snippet" : true }, "name" : "DOI", "nameEng" : "DOI", "linkPattern" : "https://doi.org/@@@", "publiclyVisible" : true, "published" : true, "oldId" : 6, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "10.1016/j.jns.2020.117252", "realUrl" : "https://doi.org/10.1016/j.jns.2020.117252", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 18740300, "link" : "/api/publicationidentifier/18740300", "label" : "WoS: 000615919600009", "source" : { "otype" : "PlainSource", "mtid" : 1, "link" : "/api/publicationsource/1", "label" : "WoS", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "WoS", "nameEng" : "WoS", "linkPattern" : "https://www.webofscience.com/wos/woscc/full-record/WOS:@@@", "publiclyVisible" : true, "published" : true, "oldId" : 1, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "000615919600009", "realUrl" : "https://www.webofscience.com/wos/woscc/full-record/WOS:000615919600009", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 18321742, "link" : "/api/publicationidentifier/18321742", "label" : "Scopus: 85097082235", "source" : { "otype" : "PlainSource", "mtid" : 3, "link" : "/api/publicationsource/3", "label" : "Scopus", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "Scopus", "linkPattern" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@", "publiclyVisible" : true, "published" : true, "oldId" : 3, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "85097082235", "realUrl" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85097082235", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 21086247, "link" : "/api/publicationidentifier/21086247", "label" : "PubMed: 33279726", "source" : { "otype" : "PlainSource", "mtid" : 17, "link" : "/api/publicationsource/17", "label" : "PubMed", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "PubMed", "nameEng" : "PubMed", "linkPattern" : "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract", "publiclyVisible" : true, "published" : true, "oldId" : 17, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "33279726", "realUrl" : "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=33279726&dopt=Abstract", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 18321741, "link" : "/api/publicationidentifier/18321741", "label" : "Egyéb URL: https://linkinghub.elsevier.com/retrieve/pii/S0022510X20305888", "source" : { "otype" : "PlainSource", "mtid" : 40, "link" : "/api/publicationsource/40", "label" : "Egyéb URL", "type" : { "otype" : "PublicationSourceType", "mtid" : 10006, "link" : "/api/publicationsourcetype/10006", "label" : "Link", "mayHaveOa" : true, "published" : true, "snippet" : true }, "name" : "Egyéb URL", "nameEng" : "Egyéb URL", "linkPattern" : "@@@", "publiclyVisible" : true, "published" : true, "oldId" : 40, "snippet" : true }, "idValue" : "https://linkinghub.elsevier.com/retrieve/pii/S0022510X20305888", "realUrl" : "https://linkinghub.elsevier.com/retrieve/pii/S0022510X20305888", "published" : false, "snippet" : true } ], "journal" : { "otype" : "Journal", "mtid" : 2702, "link" : "/api/journal/2702", "label" : "JOURNAL OF THE NEUROLOGICAL SCIENCES 0022-510X 1878-5883", "pIssn" : "0022-510X", "eIssn" : "1878-5883", "reviewType" : "REVIEWED", "noIF" : false, "sciIndexed" : true, "scopusIndexed" : true, "lang" : "FOREIGN", "hungarian" : false, "published" : true, "oldId" : 2702, "snippet" : true }, "volume" : "420", "internalId" : "117252", "firstPageOrInternalIdForSort" : "117252", "pageLength" : 11, "publishedYear" : 2021, "digital" : null, "printed" : true, "sourceYear" : 2021, "foreignEdition" : true, "foreignLanguage" : true, "fullPublication" : true, "conferencePublication" : false, "nationalOrigin" : false, "missingAuthor" : false, "oaType" : "NONE", "oaCheckDate" : "2023-02-10", "oaFree" : false, "citationCount" : 0, "citationCountUnpublished" : 0, "citationCountWoOther" : 0, "independentCitCountWoOther" : 0, "doiCitationCount" : 0, "wosCitationCount" : 0, "scopusCitationCount" : 0, "independentCitationCount" : 0, "unhandledCitationCount" : 0, "citingPubCount" : 0, "independentCitingPubCount" : 0, "unhandledCitingPubCount" : 0, "citedPubCount" : 2, "citedCount" : 2, "ratings" : [ { "otype" : "SjrRating", "mtid" : 11231115, "link" : "/api/sjrrating/11231115", "label" : "sjr:Q2 (2021) Scopus - Neurology (clinical) JOURNAL OF THE NEUROLOGICAL SCIENCES 0022-510X 1878-5883", "listPos" : 119, "rankValue" : 0.49, "type" : "journal", "ratingType" : { "otype" : "RatingType", "mtid" : 10002, "link" : "/api/ratingtype/10002", "label" : "sjr", "code" : "sjr", "published" : true, "snippet" : true }, "subject" : { "otype" : "ClassificationExternal", "mtid" : 2728, "link" : "/api/classificationexternal/2728", "label" : "Scopus - Neurology (clinical)", "published" : true, "oldId" : 2728, "snippet" : true }, "ranking" : "Q2", "calculation" : "DIRECT", "published" : true, "snippet" : true } ], "ratingsForSort" : "Q2", "references" : [ { "otype" : "Reference", "mtid" : 3191899, "link" : "/api/reference/3191899", "label" : "1. Bhalla 2017: Clinical epidemiology of single versus multiple substance use disorders: polysubstance use disorder, Med. Care, 55, p. S24, DOI: 10.1097/MLR.0000000000000731", "listPosition" : 1, "doi" : "10.1097/MLR.0000000000000731", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191900, "link" : "/api/reference/3191900", "label" : "2. Clements 2018: A systematic review of community-based interventions to improve oral chronic disease medication regimen adherence among individuals with substance use disorder, Drug Alcohol Depend., 188, p. 141, DOI: 10.1016/j.drugalcdep.2018.03.039", "listPosition" : 2, "doi" : "10.1016/j.drugalcdep.2018.03.039", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191901, "link" : "/api/reference/3191901", "label" : "3. Elias 2017: Minding the brain: the role of pharmacotherapy in substance-use disorder treatment, Dialogues Clin. Neurosci., 19, p. 289, DOI: 10.31887/DCNS.2017.19.3/hkleber", "listPosition" : 3, "doi" : "10.31887/DCNS.2017.19.3/hkleber", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191902, "link" : "/api/reference/3191902", "label" : "4. Hasin 2013: DSM-5 criteria for substance use disorders: recommendations and rationale, Am. J. Psychiatry, 170, p. 834, DOI: 10.1176/appi.ajp.2013.12060782", "listPosition" : 4, "doi" : "10.1176/appi.ajp.2013.12060782", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191903, "link" : "/api/reference/3191903", "label" : "5. Kalin 2019: New findings relevant to substance use disorders, Am. J. Psychiatry, 176, p. A10, DOI: 10.1176/appi.ajp.2018.18121421", "listPosition" : 5, "doi" : "10.1176/appi.ajp.2018.18121421", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191904, "link" : "/api/reference/3191904", "label" : "6. Klein 2016: Pharmacotherapy for substance use disorders, Med Clinics North America, 100, p. 891, DOI: 10.1016/j.mcna.2016.03.011", "listPosition" : 6, "doi" : "10.1016/j.mcna.2016.03.011", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191905, "link" : "/api/reference/3191905", "label" : "7. Marel 2019: Conditional probabilities of substance use disorders and associated risk factors: progression from first use to use disorder on alcohol, cannabis, stimulants, sedatives and opioids, Drug Alcohol Depend., 194, p. 136, DOI: 10.1016/j.drugalcdep.2018.10.010", "listPosition" : 7, "doi" : "10.1016/j.drugalcdep.2018.10.010", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191906, "link" : "/api/reference/3191906", "label" : "8. Moulahoum 2019: Novel technologies in detection, treatment and prevention of substance use disorders, J. Food Drug Anal., 27, p. 22, DOI: 10.1016/j.jfda.2018.09.003", "listPosition" : 8, "doi" : "10.1016/j.jfda.2018.09.003", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191907, "link" : "/api/reference/3191907", "label" : "9. Sartor 2019: Epigenetic pharmacotherapy for substance use disorder, Biochem. Pharmacol., 168, p. 269, DOI: 10.1016/j.bcp.2019.07.012", "listPosition" : 9, "doi" : "10.1016/j.bcp.2019.07.012", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191908, "link" : "/api/reference/3191908", "label" : "10. Volkow 2014: Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity, Proc. Natl. Acad. Sci. U. S. A., 111, p. E3149, DOI: 10.1073/pnas.1411228111", "listPosition" : 10, "doi" : "10.1073/pnas.1411228111", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191909, "link" : "/api/reference/3191909", "label" : "11. Lopez-Fando 2004: Expression of neural RGS-R7 and G[beta]5 proteins in response to acute and chronic morphine, Neuropsychopharmacology, 30, p. 99, DOI: 10.1038/sj.npp.1300515", "listPosition" : 11, "doi" : "10.1038/sj.npp.1300515", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191910, "link" : "/api/reference/3191910", "label" : "12. Darke 2017: Rates, characteristics and circumstances of methamphetamine-related death in Australia: a national 7-year study, Addiction, 112, p. 2191, DOI: 10.1111/add.13897", "listPosition" : 12, "doi" : "10.1111/add.13897", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191911, "link" : "/api/reference/3191911", "label" : "13. Kaye 2008: Methamphetamine-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology, Addiction, 103, p. 1353, DOI: 10.1111/j.1360-0443.2008.02231.x", "listPosition" : 13, "doi" : "10.1111/j.1360-0443.2008.02231.x", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191912, "link" : "/api/reference/3191912", "label" : "14. UNODC 2020", "listPosition" : 14, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191913, "link" : "/api/reference/3191913", "label" : "15. Karch 1999: Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicologic profiles, J. Forensic Sci., 44, p. 359, DOI: 10.1520/JFS14464J", "listPosition" : 15, "doi" : "10.1520/JFS14464J", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191914, "link" : "/api/reference/3191914", "label" : "16. Shukla 2012: An evolving problem: methamphetamine production and trafficking in the United States, Int. J. Drug Policy, 23, p. 426, DOI: 10.1016/j.drugpo.2012.07.004", "listPosition" : 16, "doi" : "10.1016/j.drugpo.2012.07.004", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191915, "link" : "/api/reference/3191915", "label" : "17. Gettig 2006: Methamphetamine: putting the brakes on speed, J. Sch. Nurs., 22, p. 66, DOI: 10.1177/105984050602200202", "listPosition" : 17, "doi" : "10.1177/105984050602200202", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191916, "link" : "/api/reference/3191916", "label" : "18. Lappin 2019: Psychostimulant use and the brain, Addiction, 114, p. 2065, DOI: 10.1111/add.14708", "listPosition" : 18, "doi" : "10.1111/add.14708", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191917, "link" : "/api/reference/3191917", "label" : "19. Shaerzadeh 2018: Methamphetamine neurotoxicity, microglia, and neuroinflammation, J. Neuroinflammation, 15, p. 341, DOI: 10.1186/s12974-018-1385-0", "listPosition" : 19, "doi" : "10.1186/s12974-018-1385-0", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191918, "link" : "/api/reference/3191918", "label" : "20. Krasnova 2009: Methamphetamine toxicity and messengers of death, Brain Res. Rev., 60, p. 379, DOI: 10.1016/j.brainresrev.2009.03.002", "listPosition" : 20, "doi" : "10.1016/j.brainresrev.2009.03.002", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191919, "link" : "/api/reference/3191919", "label" : "21. Ropek 2019: Methamphetamine (“crystal meth”) causes induction of DNA damage and chromosomal aberrations in human derived cells, Food Chem. Toxicol., 128, p. 1, DOI: 10.1016/j.fct.2019.03.035", "listPosition" : 21, "doi" : "10.1016/j.fct.2019.03.035", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191920, "link" : "/api/reference/3191920", "label" : "22. Schepers 2003: Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers, Clin. Chem., 49, p. 121, DOI: 10.1373/49.1.121", "listPosition" : 22, "doi" : "10.1373/49.1.121", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191921, "link" : "/api/reference/3191921", "label" : "23. Schep 2010: The clinical toxicology of metamfetamine, Clin Toxicol (Phila), 48, p. 675, DOI: 10.3109/15563650.2010.516752", "listPosition" : 23, "doi" : "10.3109/15563650.2010.516752", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191922, "link" : "/api/reference/3191922", "label" : "24. Richards 2015: Treatment of toxicity from amphetamines, related derivatives, and analogues: a systematic clinical review, Drug Alcohol Depend., 150, p. 1, DOI: 10.1016/j.drugalcdep.2015.01.040", "listPosition" : 24, "doi" : "10.1016/j.drugalcdep.2015.01.040", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191923, "link" : "/api/reference/3191923", "label" : "25. Cumming 2020: Methamphetamine use, health and criminal justice system outcomes: a systematic review, Drug Alcohol Rev., 39, p. 505, DOI: 10.1111/dar.13062", "listPosition" : 25, "doi" : "10.1111/dar.13062", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191924, "link" : "/api/reference/3191924", "label" : "26. Kim 2004: Urinary pharmacokinetics of methamphetamine and its metabolite, amphetamine following controlled oral administration to humans, Ther. Drug Monit., 26, p. 664, DOI: 10.1097/00007691-200412000-00013", "listPosition" : 26, "doi" : "10.1097/00007691-200412000-00013", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191925, "link" : "/api/reference/3191925", "label" : "27. Ramamoorthy 2001: Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic activity for multiple substrates, Pharmacogenetics, 11, p. 477, DOI: 10.1097/00008571-200108000-00003", "listPosition" : 27, "doi" : "10.1097/00008571-200108000-00003", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191926, "link" : "/api/reference/3191926", "label" : "28. Homer 2008: Methamphetamine abuse and impairment of social functioning: a review of the underlying neurophysiological causes and behavioral implications, Psychol. Bull., 134, p. 301, DOI: 10.1037/0033-2909.134.2.301", "listPosition" : 28, "doi" : "10.1037/0033-2909.134.2.301", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191927, "link" : "/api/reference/3191927", "label" : "29. Albertson 1999: Methamphetamine and the expanding complications of amphetamines, West J. Med., 170, p. 214", "listPosition" : 29, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191928, "link" : "/api/reference/3191928", "label" : "30. Murray 1998: Psychophysiological aspects of amphetamine-methamphetamine abuse, J. Psychol., 132, p. 227, DOI: 10.1080/00223989809599162", "listPosition" : 30, "doi" : "10.1080/00223989809599162", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191929, "link" : "/api/reference/3191929", "label" : "31. Meredith 2005: Implications of chronic methamphetamine use: a literature review, Harv Rev Psychiatry, 13, p. 141, DOI: 10.1080/10673220591003605", "listPosition" : 31, "doi" : "10.1080/10673220591003605", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191930, "link" : "/api/reference/3191930", "label" : "32. Barr 2006: The need for speed: an update on methamphetamine addiction, J. Psychiatry Neurosci., 31, p. 301", "listPosition" : 32, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191931, "link" : "/api/reference/3191931", "label" : "33. Scott 2007: Neurocognitive effects of methamphetamine: a critical review and meta-analysis, Neuropsychol. Rev., 17, p. 275, DOI: 10.1007/s11065-007-9031-0", "listPosition" : 33, "doi" : "10.1007/s11065-007-9031-0", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191932, "link" : "/api/reference/3191932", "label" : "34. Weber 2017: Medico-legal assessment of methamphetamine and amphetamine serum concentrations-what can we learn from survived intoxications?, Int. J. Legal Med., 131, p. 1253, DOI: 10.1007/s00414-017-1607-5", "listPosition" : 34, "doi" : "10.1007/s00414-017-1607-5", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191933, "link" : "/api/reference/3191933", "label" : "35. Wang 2018: Disappearance of R/S-methamphetamine and R/S-amphetamine from human scalp hair after discontinuation of methamphetamine abuse, Forensic Sci. Int., 284, p. 153, DOI: 10.1016/j.forsciint.2018.01.011", "listPosition" : 35, "doi" : "10.1016/j.forsciint.2018.01.011", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191934, "link" : "/api/reference/3191934", "label" : "36. Callaghan 2012: Increased risk of Parkinson’s disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs, Drug Alcohol Depend., 120, p. 35, DOI: 10.1016/j.drugalcdep.2011.06.013", "listPosition" : 36, "doi" : "10.1016/j.drugalcdep.2011.06.013", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191935, "link" : "/api/reference/3191935", "label" : "37. Sekine 2008: MS Gold, JL Cadet, Methamphetamine causes microglial activation in the brains of human abusers, J. Neurosci., 28, p. 5756, DOI: 10.1523/JNEUROSCI.1179-08.2008", "listPosition" : 37, "doi" : "10.1523/JNEUROSCI.1179-08.2008", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191936, "link" : "/api/reference/3191936", "label" : "38. Smith 2012: Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases, Brain Res. Bull., 87, p. 10, DOI: 10.1016/j.brainresbull.2011.10.004", "listPosition" : 38, "doi" : "10.1016/j.brainresbull.2011.10.004", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191937, "link" : "/api/reference/3191937", "label" : "39. Bassani 2015: Neuroinflammation in the pathophysiology of Parkinson’s disease and therapeutic evidence of anti-inflammatory drugs, Arq. Neuropsiquiatr., 73, p. 616, DOI: 10.1590/0004-282X20150057", "listPosition" : 39, "doi" : "10.1590/0004-282X20150057", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191938, "link" : "/api/reference/3191938", "label" : "40. Downes 2005: Amphetamine-induced movement disorder, Emerg. Med. Australas, 17, p. 277, DOI: 10.1111/j.1742-6723.2005.00735.x", "listPosition" : 40, "doi" : "10.1111/j.1742-6723.2005.00735.x", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191939, "link" : "/api/reference/3191939", "label" : "41. Rylander 1972: Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs, Psychiatr. Neurol. Neurochir., 75, p. 203", "listPosition" : 41, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191940, "link" : "/api/reference/3191940", "label" : "42. Siemsen 2019: Effects of Methamphetamine self-administration and extinction on astrocyte structure and function in the nucleus Accumbens Core, Neuroscience, 406, p. 528, DOI: 10.1016/j.neuroscience.2019.03.040", "listPosition" : 42, "doi" : "10.1016/j.neuroscience.2019.03.040", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191941, "link" : "/api/reference/3191941", "label" : "43. Bershad 2015: Effects of acute doses of prosocial drugs methamphetamine and alcohol on plasma oxytocin levels, J. Clin. Psychopharmacol., 35, p. 308, DOI: 10.1097/JCP.0000000000000314", "listPosition" : 43, "doi" : "10.1097/JCP.0000000000000314", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191942, "link" : "/api/reference/3191942", "label" : "44. Kirkpatrick 2013: In the company of others: social factors alter acute alcohol effects, Psychopharmacology, 230, p. 215, DOI: 10.1007/s00213-013-3147-0", "listPosition" : 44, "doi" : "10.1007/s00213-013-3147-0", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191943, "link" : "/api/reference/3191943", "label" : "45. Blum 2020: Molecular neurological correlates of endorphinergic/dopaminergic mechanisms in reward circuitry linked to endorphinergic deficiency syndrome (EDS), J. Neurol. Sci., 411, p. 116733, DOI: 10.1016/j.jns.2020.116733", "listPosition" : 45, "doi" : "10.1016/j.jns.2020.116733", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191944, "link" : "/api/reference/3191944", "label" : "46. Blum 2019: Opioid substitution therapy: achieving harm reduction while searching for a prophylactic solution, Curr. Pharm. Biotechnol., 20, p. 180, DOI: 10.2174/138920102003190422150527", "listPosition" : 46, "doi" : "10.2174/138920102003190422150527", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191945, "link" : "/api/reference/3191945", "label" : "47. Castells 2016: Psychostimulant drugs for cocaine dependence, Cochrane Database Syst. Rev., 9", "listPosition" : 47, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191946, "link" : "/api/reference/3191946", "label" : "48. Guo 2019: Inhibition of naltrexone on relapse in methamphetamine self-administration and conditioned place preference in rats, Eur. J. Pharmacol., 865, p. 172671, DOI: 10.1016/j.ejphar.2019.172671", "listPosition" : 48, "doi" : "10.1016/j.ejphar.2019.172671", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191947, "link" : "/api/reference/3191947", "label" : "49. Hart 2012: Is cognitive functioning impaired in methamphetamine users? A critical review, Neuropsychopharmacology, 37, p. 586, DOI: 10.1038/npp.2011.276", "listPosition" : 49, "doi" : "10.1038/npp.2011.276", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191948, "link" : "/api/reference/3191948", "label" : "50. Sokoloff 2017: The dopamine D3 receptor, a quarter century later, Eur. J. Neurosci., 45, p. 2, DOI: 10.1111/ejn.13390", "listPosition" : 50, "doi" : "10.1111/ejn.13390", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191949, "link" : "/api/reference/3191949", "label" : "51. Chang 2018: A review of risk factors for Methamphetamine-related psychiatric symptoms, Front Psychiatry, 9, p. 603, DOI: 10.3389/fpsyt.2018.00603", "listPosition" : 51, "doi" : "10.3389/fpsyt.2018.00603", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191950, "link" : "/api/reference/3191950", "label" : "52. Zweben 2004: Psychiatric symptoms in methamphetamine users, Am. J. Addict., 13, p. 181, DOI: 10.1080/10550490490436055", "listPosition" : 52, "doi" : "10.1080/10550490490436055", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191951, "link" : "/api/reference/3191951", "label" : "53. de Leon 1992: Delusion of parasitosis or chronic tactile hallucinosis: hypothesis about their brain physiopathology, Compr. Psychiatry, 33, p. 25, DOI: 10.1016/0010-440X(92)90075-2", "listPosition" : 53, "doi" : "10.1016/0010-440X(92)90075-2", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191952, "link" : "/api/reference/3191952", "label" : "54. Hinkle 2010: Ekbom syndrome: the challenge of “invisible bug” infestations, Annu. Rev. Entomol., 55, p. 77, DOI: 10.1146/annurev.ento.54.110807.090514", "listPosition" : 54, "doi" : "10.1146/annurev.ento.54.110807.090514", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191953, "link" : "/api/reference/3191953", "label" : "55. JL Cadet 2014: Neuropathology of substance use disorders, Acta Neuropathol., 127, p. 91, DOI: 10.1007/s00401-013-1221-7", "listPosition" : 55, "doi" : "10.1007/s00401-013-1221-7", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191954, "link" : "/api/reference/3191954", "label" : "56. TA Wearne 2018: Comparison of Methamphetamine-induced psychosis and schizophrenia: a review of positive, negative, and cognitive symptomatology, Front. Psychiatry, 9, p. 491, DOI: 10.3389/fpsyt.2018.00491", "listPosition" : 56, "doi" : "10.3389/fpsyt.2018.00491", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191955, "link" : "/api/reference/3191955", "label" : "57. Guerin 2019: Cognition and related neural findings on Methamphetamine use disorder: insights and Treatment implications from schizophrenia research, Front. Psychiatry, 10, p. 880, DOI: 10.3389/fpsyt.2019.00880", "listPosition" : 57, "doi" : "10.3389/fpsyt.2019.00880", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191956, "link" : "/api/reference/3191956", "label" : "58. Gao 2019: Long non-coding RNA MEG3 attends to morphine-mediated autophagy of HT22 cells through modulating ERK pathway, Pharm. Biol., 57, p. 536, DOI: 10.1080/13880209.2019.1651343", "listPosition" : 58, "doi" : "10.1080/13880209.2019.1651343", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191957, "link" : "/api/reference/3191957", "label" : "59. Li 2018: Relationship between schizophrenia and changes in the expression of the long non-coding RNAs Meg3, Miat, Neat1 and Neat2, J. Psychiatr. Res., 106, p. 22, DOI: 10.1016/j.jpsychires.2018.09.005", "listPosition" : 59, "doi" : "10.1016/j.jpsychires.2018.09.005", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191958, "link" : "/api/reference/3191958", "label" : "60. LB Areal 2017: Crack cocaine inhalation induces schizophrenia-like symptoms and molecular alterations in mice prefrontal cortex, J. Psychiatr. Res., 91, p. 57, DOI: 10.1016/j.jpsychires.2017.03.005", "listPosition" : 60, "doi" : "10.1016/j.jpsychires.2017.03.005", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191959, "link" : "/api/reference/3191959", "label" : "61. LB Areal 2015: Behavioural, biochemical and molecular changes induced by chronic crack-cocaine inhalation in mice: the role of dopaminergic and endocannabinoid systems in the prefrontal cortex, Behav. Brain Res., 290, p. 8, DOI: 10.1016/j.bbr.2015.04.036", "listPosition" : 61, "doi" : "10.1016/j.bbr.2015.04.036", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191960, "link" : "/api/reference/3191960", "label" : "62. JL Cadet 2009: Molecular bases of methamphetamine-induced neurodegeneration, Int. Rev. Neurobiol., 88, p. 101, DOI: 10.1016/S0074-7742(09)88005-7", "listPosition" : 62, "doi" : "10.1016/S0074-7742(09)88005-7", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191961, "link" : "/api/reference/3191961", "label" : "63. Hazin 2009: Ocular manifestations of crystal methamphetamine use, Neurotox. Res., 15, p. 187, DOI: 10.1007/s12640-009-9019-z", "listPosition" : 63, "doi" : "10.1007/s12640-009-9019-z", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191962, "link" : "/api/reference/3191962", "label" : "64. Darke 2018: Clinical characteristics of fatal Methamphetamine-related stroke: a National Study, J. Forensic Sci., 63, p. 735, DOI: 10.1111/1556-4029.13620", "listPosition" : 64, "doi" : "10.1111/1556-4029.13620", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191963, "link" : "/api/reference/3191963", "label" : "65. EL Ho 2009: Cerebrovascular complications of methamphetamine abuse, Neurocrit. Care., 10, p. 295, DOI: 10.1007/s12028-008-9177-5", "listPosition" : 65, "doi" : "10.1007/s12028-008-9177-5", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191964, "link" : "/api/reference/3191964", "label" : "66. Isoardi 2019: Methamphetamine presentations to an emergency department: management and complications, Emerg. Med. Australas, 31, p. 593, DOI: 10.1111/1742-6723.13219", "listPosition" : 66, "doi" : "10.1111/1742-6723.13219", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191965, "link" : "/api/reference/3191965", "label" : "67. Kaku 1990: Emergence of recreational drug abuse as a major risk factor for stroke in young adults, Ann. Intern. Med., 113, p. 821, DOI: 10.7326/0003-4819-113-11-821", "listPosition" : 67, "doi" : "10.7326/0003-4819-113-11-821", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191966, "link" : "/api/reference/3191966", "label" : "68. Lappin 2017: Stroke and methamphetamine use in young adults: a review, J. Neurol. Neurosurg. Psychiatry, 88, p. 1079, DOI: 10.1136/jnnp-2017-316071", "listPosition" : 68, "doi" : "10.1136/jnnp-2017-316071", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191967, "link" : "/api/reference/3191967", "label" : "69. Logan 1998: Cause and manner of death in fatalities involving methamphetamine, J. Forensic Sci., 43, p. 28, DOI: 10.1520/JFS16085J", "listPosition" : 69, "doi" : "10.1520/JFS16085J", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191968, "link" : "/api/reference/3191968", "label" : "70. Perez 1999: Methamphetamine-related stroke: four cases, J. Emerg. Med., 17, p. 469, DOI: 10.1016/S0736-4679(99)00009-8", "listPosition" : 70, "doi" : "10.1016/S0736-4679(99)00009-8", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191969, "link" : "/api/reference/3191969", "label" : "71. Westover 2007: Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients, Arch. Gen. Psychiatry, 64, p. 495, DOI: 10.1001/archpsyc.64.4.495", "listPosition" : 71, "doi" : "10.1001/archpsyc.64.4.495", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191970, "link" : "/api/reference/3191970", "label" : "72. Huang 2016: Risk of cardiovascular diseases and stroke events in Methamphetamine users: a 10-year follow-up study, J. Clin. Psychiatry, 77, p. 1396, DOI: 10.4088/JCP.15m09872", "listPosition" : 72, "doi" : "10.4088/JCP.15m09872", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191971, "link" : "/api/reference/3191971", "label" : "73. Moon 2015: Methamphetamine use is an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage, J Neurointerv Surg., 7, p. 346, DOI: 10.1136/neurintsurg-2014-011161", "listPosition" : 73, "doi" : "10.1136/neurintsurg-2014-011161", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191972, "link" : "/api/reference/3191972", "label" : "74. Beadell 2012: The deleterious effects of methamphetamine use on initial presentation and clinical outcomes in aneurysmal subarachnoid hemorrhage, J. Neurosurg., 117, p. 781, DOI: 10.3171/2012.7.JNS12396", "listPosition" : 74, "doi" : "10.3171/2012.7.JNS12396", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191973, "link" : "/api/reference/3191973", "label" : "75. Bostwick 1981: Amphetamine induced cerebral vasculitis, Hum. Pathol., 12, p. 1031, DOI: 10.1016/S0046-8177(81)80262-6", "listPosition" : 75, "doi" : "10.1016/S0046-8177(81)80262-6", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191974, "link" : "/api/reference/3191974", "label" : "76. Margolis 1971: Methamphetamine (“speed”) arteritis, Neuroradiology, 2, p. 179, DOI: 10.1007/BF00335049", "listPosition" : 76, "doi" : "10.1007/BF00335049", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191975, "link" : "/api/reference/3191975", "label" : "77. Rothrock 1988: Ischemic stroke associated with methamphetamine inhalation, Neurology, 38, p. 589, DOI: 10.1212/WNL.38.4.589", "listPosition" : 77, "doi" : "10.1212/WNL.38.4.589", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191976, "link" : "/api/reference/3191976", "label" : "78. Uekusa 2013: Methamphetamine and amphetamine concentrations in survivors of body-packer syndrome in Japan, Forensic Sci. Int., 227, p. 45, DOI: 10.1016/j.forsciint.2012.10.005", "listPosition" : 78, "doi" : "10.1016/j.forsciint.2012.10.005", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191977, "link" : "/api/reference/3191977", "label" : "79. Hu 2018: Rhabdomyolysis observed at forensic autopsy: a series of 52 cases, Forensic. Sci. Med. Pathol., 14, p. 424, DOI: 10.1007/s12024-018-0003-x", "listPosition" : 79, "doi" : "10.1007/s12024-018-0003-x", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191978, "link" : "/api/reference/3191978", "label" : "80. Cervellin 2017: Non-traumatic Rhabdomyolysis: background, laboratory features, and acute clinical management, Clin. Biochem., 50, p. 656, DOI: 10.1016/j.clinbiochem.2017.02.016", "listPosition" : 80, "doi" : "10.1016/j.clinbiochem.2017.02.016", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191979, "link" : "/api/reference/3191979", "label" : "81. Matsumoto 2014: Methamphetamine-induced toxicity: an updated review on issues related to hyperthermia, Pharmacol. Ther., 144, p. 28, DOI: 10.1016/j.pharmthera.2014.05.001", "listPosition" : 81, "doi" : "10.1016/j.pharmthera.2014.05.001", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191980, "link" : "/api/reference/3191980", "label" : "82. Matsusue 2011: Genetic analysis of the rhabdomyolysis-associated genes in forensic autopsy cases of methamphetamine abusers, Leg Med (Tokyo), 13, p. 7, DOI: 10.1016/j.legalmed.2010.08.007", "listPosition" : 82, "doi" : "10.1016/j.legalmed.2010.08.007", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191981, "link" : "/api/reference/3191981", "label" : "83. Callaghan 2010: Incidence of Parkinson’s disease among hospital patients with methamphetamine-use disorders, Mov. Disord., 25, p. 2333, DOI: 10.1002/mds.23263", "listPosition" : 83, "doi" : "10.1002/mds.23263", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191982, "link" : "/api/reference/3191982", "label" : "84. Meshkin 2008: 12, p. 25", "listPosition" : 84, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191983, "link" : "/api/reference/3191983", "label" : "85. Lundh 1981: An extrapyramidal choreiform syndrome caused by amphetamine addiction, J. Neurol. Neurosurg. Psychiatry, 44, p. 728, DOI: 10.1136/jnnp.44.8.728", "listPosition" : 85, "doi" : "10.1136/jnnp.44.8.728", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191984, "link" : "/api/reference/3191984", "label" : "86. Schiorring 1981: Psychopathology induced by “speed drugs”, Pharmacol. Biochem. Behav., 14, p. 109, DOI: 10.1016/S0091-3057(81)80018-4", "listPosition" : 86, "doi" : "10.1016/S0091-3057(81)80018-4", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191985, "link" : "/api/reference/3191985", "label" : "87. Beaulieu-Boire 2015: Behavioral effects of levodopa, Mov. Disord., 30, p. 90, DOI: 10.1002/mds.26121", "listPosition" : 87, "doi" : "10.1002/mds.26121", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191986, "link" : "/api/reference/3191986", "label" : "88. Rhee 1988: Choreoathetoid disorder associated with amphetamine-like drugs, Am. J. Emerg. Med., 6, p. 131, DOI: 10.1016/0735-6757(88)90050-2", "listPosition" : 88, "doi" : "10.1016/0735-6757(88)90050-2", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191987, "link" : "/api/reference/3191987", "label" : "89. Blum 2016: Hypothesizing that, a pro-dopamine regulator (KB220Z) should optimize, but not hyper-activate the activity of trace amine-associated receptor 1 (TAAR-1) and induce anti-craving of Psychostimulants in the long-term, J. Reward Defic. Syndr. Addict. Sci., 2, p. 14, DOI: 10.17756/jrdsas.2016-023", "listPosition" : 89, "doi" : "10.17756/jrdsas.2016-023", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191988, "link" : "/api/reference/3191988", "label" : "90. Borowsky 2001: Trace amines: identification of a family of mammalian G protein-coupled receptors, Proc. Natl. Acad. Sci. U. S. A., 98, p. 8966, DOI: 10.1073/pnas.151105198", "listPosition" : 90, "doi" : "10.1073/pnas.151105198", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191989, "link" : "/api/reference/3191989", "label" : "91. Burchett 2006: The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain, Prog. Neurobiol., 79, p. 223, DOI: 10.1016/j.pneurobio.2006.07.003", "listPosition" : 91, "doi" : "10.1016/j.pneurobio.2006.07.003", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191990, "link" : "/api/reference/3191990", "label" : "92. Revel 2013: A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight, Mol. Psychiatry, 18, p. 543, DOI: 10.1038/mp.2012.57", "listPosition" : 92, "doi" : "10.1038/mp.2012.57", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191991, "link" : "/api/reference/3191991", "label" : "93. Jing 2015: Trace amine-associated receptor 1: a promising target for the treatment of psychostimulant addiction, Eur. J. Pharmacol., 761, p. 345, DOI: 10.1016/j.ejphar.2015.06.019", "listPosition" : 93, "doi" : "10.1016/j.ejphar.2015.06.019", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191992, "link" : "/api/reference/3191992", "label" : "94. Revel 2012: Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics, Biol. Psychiatry, 72, p. 934, DOI: 10.1016/j.biopsych.2012.05.014", "listPosition" : 94, "doi" : "10.1016/j.biopsych.2012.05.014", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191993, "link" : "/api/reference/3191993", "label" : "95. Bradaia 2009: The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system, Proc. Natl. Acad. Sci. U. S. A., 106, p. 20081, DOI: 10.1073/pnas.0906522106", "listPosition" : 95, "doi" : "10.1073/pnas.0906522106", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191994, "link" : "/api/reference/3191994", "label" : "96. Xie 2009: Trace amine-associated receptor 1 as a monoaminergic modulator in brain, Biochem. Pharmacol., 78, p. 1095, DOI: 10.1016/j.bcp.2009.05.031", "listPosition" : 96, "doi" : "10.1016/j.bcp.2009.05.031", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191995, "link" : "/api/reference/3191995", "label" : "97. Blum 2012: “Liking” and “wanting” linked to reward deficiency syndrome (RDS): hypothesizing differential responsivity in brain reward circuitry, Curr. Pharm. Des., 18, p. 113, DOI: 10.2174/138161212798919110", "listPosition" : 97, "doi" : "10.2174/138161212798919110", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191996, "link" : "/api/reference/3191996", "label" : "98. Blum 2019: Americas’ opioid/psychostimulant epidemic would benefit from general population early identification of genetic addiction risk especially in children of alcoholics (COAs), J. Syst. Integr. Neurosci., 5, p. 1", "listPosition" : 98, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191997, "link" : "/api/reference/3191997", "label" : "99. Wheeler 2009: Genetically correlated effects of selective breeding for high and low methamphetamine consumption, Genes Brain Behav., 8, p. 758, DOI: 10.1111/j.1601-183X.2009.00522.x", "listPosition" : 99, "doi" : "10.1111/j.1601-183X.2009.00522.x", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191998, "link" : "/api/reference/3191998", "label" : "100. Barbier 2008: Long-term alterations in vulnerability to addiction to drugs of abuse and in brain gene expression after early life ethanol exposure, Neuropharmacology, 55, p. 1199, DOI: 10.1016/j.neuropharm.2008.07.030", "listPosition" : 100, "doi" : "10.1016/j.neuropharm.2008.07.030", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3191999, "link" : "/api/reference/3191999", "label" : "101. Márquez 2017: Glutamate and brain Glutaminases in drug addiction, Neurochem. Res., 42, p. 846, DOI: 10.1007/s11064-016-2137-0", "listPosition" : 101, "doi" : "10.1007/s11064-016-2137-0", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192000, "link" : "/api/reference/3192000", "label" : "102. Blanco 2012: Cocaine modulates both glutaminase gene expression and glutaminase activity in the brain of cocaine-sensitized mice, Psychopharmacology, 219, p. 933, DOI: 10.1007/s00213-011-2418-x", "listPosition" : 102, "doi" : "10.1007/s00213-011-2418-x", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192001, "link" : "/api/reference/3192001", "label" : "103. TA Wearne 2016: GABAergic mRNA expression is upregulated in the prefrontal cortex of rats sensitized to methamphetamine, Behav. Brain Res., 297, p. 224, DOI: 10.1016/j.bbr.2015.10.026", "listPosition" : 103, "doi" : "10.1016/j.bbr.2015.10.026", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192002, "link" : "/api/reference/3192002", "label" : "104. Le Foll 2009: Genetics of dopamine receptors and drug addiction: a comprehensive review, Behav. Pharmacol., 20, p. 1, DOI: 10.1097/FBP.0b013e3283242f05", "listPosition" : 104, "doi" : "10.1097/FBP.0b013e3283242f05", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192003, "link" : "/api/reference/3192003", "label" : "105. Solís 2019: Moratalla, Behavioral sensitization and cellular responses to psychostimulants are reduced in D2R knockout mice, Addict. Biol., p. e12840", "listPosition" : 105, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192004, "link" : "/api/reference/3192004", "label" : "106. FW Lohoff 2008: Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence, Neuropsychopharmacology, 33, p. 3078, DOI: 10.1038/npp.2008.126", "listPosition" : 106, "doi" : "10.1038/npp.2008.126", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192005, "link" : "/api/reference/3192005", "label" : "107. Noble 1993: Allelic association of the D2 dopamine receptor gene with cocaine dependence, Drug Alcohol Depend., 33, p. 271, DOI: 10.1016/0376-8716(93)90113-5", "listPosition" : 107, "doi" : "10.1016/0376-8716(93)90113-5", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192006, "link" : "/api/reference/3192006", "label" : "108. Blackwood 2019: Escalated oxycodone self-administration and punishment: differential expression of opioid receptors and immediate early genes in the rat dorsal striatum and prefrontal cortex, Front. Neurosci., 13, p. 1392, DOI: 10.3389/fnins.2019.01392", "listPosition" : 108, "doi" : "10.3389/fnins.2019.01392", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192007, "link" : "/api/reference/3192007", "label" : "109. Bryant 2009: A major QTL on chromosome 11 influences psychostimulant and opioid sensitivity in mice, Genes Brain Behav., 8, p. 795, DOI: 10.1111/j.1601-183X.2009.00525.x", "listPosition" : 109, "doi" : "10.1111/j.1601-183X.2009.00525.x", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192008, "link" : "/api/reference/3192008", "label" : "110. RA Wise 1987: Bozarth, a psychomotor stimulant theory of addiction, Psychol. Rev., 94, p. 469, DOI: 10.1037/0033-295X.94.4.469", "listPosition" : 110, "doi" : "10.1037/0033-295X.94.4.469", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192009, "link" : "/api/reference/3192009", "label" : "111. Ouimet 1984: DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization, J. Neurosci., 4, p. 111, DOI: 10.1523/JNEUROSCI.04-01-00111.1984", "listPosition" : 111, "doi" : "10.1523/JNEUROSCI.04-01-00111.1984", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192010, "link" : "/api/reference/3192010", "label" : "112. AA Fienberg 1998: DARPP-32: regulator of the efficacy of dopaminergic neurotransmission, Science, 281, p. 838, DOI: 10.1126/science.281.5378.838", "listPosition" : 112, "doi" : "10.1126/science.281.5378.838", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192011, "link" : "/api/reference/3192011", "label" : "113. Borgkvist 2007: Activation of the cAMP/PKA/DARPP-32 signaling pathway is required for morphine psychomotor stimulation but not for morphine reward, Neuropsychopharmacology, 32, p. 1995, DOI: 10.1038/sj.npp.1301321", "listPosition" : 113, "doi" : "10.1038/sj.npp.1301321", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192012, "link" : "/api/reference/3192012", "label" : "114. Kotyuk 2020: Co-occurrences of substance use and other potentially addictive behaviors: epidemiological results from the psychological and genetic factors of the addictive Behaviors (PGA) study, J. Behav. Addict., 9, p. 272, DOI: 10.1556/2006.2020.00033", "listPosition" : 114, "doi" : "10.1556/2006.2020.00033", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192013, "link" : "/api/reference/3192013", "label" : "115. Bisagno 2019: Expression of immediate early genes in brain reward circuitries: differential regulation by psychostimulant and opioid drugs, Neurochem. Int., 124, p. 10, DOI: 10.1016/j.neuint.2018.12.004", "listPosition" : 115, "doi" : "10.1016/j.neuint.2018.12.004", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192014, "link" : "/api/reference/3192014", "label" : "116. Dlugos 2011: OPRM1 gene variants modulate amphetamine-induced euphoria in humans, Genes Brain Behav., 10, p. 199, DOI: 10.1111/j.1601-183X.2010.00655.x", "listPosition" : 116, "doi" : "10.1111/j.1601-183X.2010.00655.x", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192015, "link" : "/api/reference/3192015", "label" : "117. JL Cadet 2015: Neuropsychological consequences of chronic drug use: relevance to Treatment approaches, Front Psychiatry, 6, p. 189", "listPosition" : 117, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192016, "link" : "/api/reference/3192016", "label" : "118. Rendell 2009: Prospective memory impairment in former users of methamphetamine, Psychopharmacology, 203, p. 609, DOI: 10.1007/s00213-008-1408-0", "listPosition" : 118, "doi" : "10.1007/s00213-008-1408-0", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192017, "link" : "/api/reference/3192017", "label" : "119. Bechara 2002: Decision-making and addiction (part I): impaired activation of somatic states in substance dependent individuals when pondering decisions with negative future consequences, Neuropsychologia, 40, p. 1675, DOI: 10.1016/S0028-3932(02)00015-5", "listPosition" : 119, "doi" : "10.1016/S0028-3932(02)00015-5", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192018, "link" : "/api/reference/3192018", "label" : "120. Blum 2015: Neurogenetics and gene therapy for reward deficiency syndrome: are we going to the promised land?, Expert. Opin. Biol. Ther., 15, p. 973, DOI: 10.1517/14712598.2015.1045871", "listPosition" : 120, "doi" : "10.1517/14712598.2015.1045871", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192019, "link" : "/api/reference/3192019", "label" : "121. Thanos 2008: D2R DNA transfer into the nucleus accumbens attenuates cocaine self-administration in rats, Synapse (New York, N.Y.), 62, p. 481, DOI: 10.1002/syn.20523", "listPosition" : 121, "doi" : "10.1002/syn.20523", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192020, "link" : "/api/reference/3192020", "label" : "122. Dackis 1985: New concepts in cocaine addiction: the dopamine depletion hypothesis, Neurosci. Biobehav. Rev., 9, p. 469, DOI: 10.1016/0149-7634(85)90022-3", "listPosition" : 122, "doi" : "10.1016/0149-7634(85)90022-3", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192021, "link" : "/api/reference/3192021", "label" : "123. Bogomolova 2010: Dopamine down-regulates activity of alkaline phosphatase in drosophila: the role of D2-like receptors, J. Insect Physiol., 56, p. 1155, DOI: 10.1016/j.jinsphys.2010.03.014", "listPosition" : 123, "doi" : "10.1016/j.jinsphys.2010.03.014", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192022, "link" : "/api/reference/3192022", "label" : "124. Brown 1990: Neurodynamics of relapse prevention: a neuronutrient approach to outpatient DUI offenders, J. Psychoactive Drugs, 22, p. 173, DOI: 10.1080/02791072.1990.10472542", "listPosition" : 124, "doi" : "10.1080/02791072.1990.10472542", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192023, "link" : "/api/reference/3192023", "label" : "125. Blum 1988: Reduction of both drug hunger and withdrawal against advice rate of cocaine abusers in a 30 day in-patient treatment program by the neuronutrient Tropamine, Curr. Ther. Res., 43, p. 1204", "listPosition" : 125, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192024, "link" : "/api/reference/3192024", "label" : "126. Cold 1996: JA, NeuRecover-SATM in the Treatment of cocaine withdrawal and craving: a pilot study, Clin. Drug Investig., 12, p. 1, DOI: 10.2165/00044011-199612010-00001", "listPosition" : 126, "doi" : "10.2165/00044011-199612010-00001", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192025, "link" : "/api/reference/3192025", "label" : "127. Blum 2010: Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D(2) agonist therapy: part 2, Postgrad. Med., 122, p. 214, DOI: 10.3810/pgm.2010.11.2237", "listPosition" : 127, "doi" : "10.3810/pgm.2010.11.2237", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192026, "link" : "/api/reference/3192026", "label" : "128. Blum 2017: “Dopamine homeostasis” requires balanced polypharmacy: issue with destructive, powerful dopamine agents to combat America’s drug epidemic, J. Syst. Integr. Neurosci., 3, DOI: 10.15761/JSIN.1000183", "listPosition" : 128, "doi" : "10.15761/JSIN.1000183", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192027, "link" : "/api/reference/3192027", "label" : "129. Volkow 2013: Unbalanced neuronal circuits in addiction, Curr. Opin. Neurobiol., 23, p. 639, DOI: 10.1016/j.conb.2013.01.002", "listPosition" : 129, "doi" : "10.1016/j.conb.2013.01.002", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192028, "link" : "/api/reference/3192028", "label" : "130. McKetin 2017: A potential role for N-acetylcysteine in the management of methamphetamine dependence, Drug Alcohol Rev., 36, p. 153, DOI: 10.1111/dar.12414", "listPosition" : 130, "doi" : "10.1111/dar.12414", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192029, "link" : "/api/reference/3192029", "label" : "131. Bergman 2013: Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors, Int. J. Neuropsychopharmacol., 16, p. 445, DOI: 10.1017/S1461145712000661", "listPosition" : 131, "doi" : "10.1017/S1461145712000661", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192030, "link" : "/api/reference/3192030", "label" : "132. Kosten 2013: Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylase, Biol. Psychiatry, 73, p. 219, DOI: 10.1016/j.biopsych.2012.07.011", "listPosition" : 132, "doi" : "10.1016/j.biopsych.2012.07.011", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192031, "link" : "/api/reference/3192031", "label" : "133. Swanepoel 2018: N-acetyl cysteine reverses bio-behavioural changes induced by prenatal inflammation, adolescent methamphetamine exposure and combined challenges, Psychopharmacology, 235, p. 351, DOI: 10.1007/s00213-017-4776-5", "listPosition" : 133, "doi" : "10.1007/s00213-017-4776-5", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192032, "link" : "/api/reference/3192032", "label" : "134. González 2018: Repeated methamphetamine and modafinil induce differential cognitive effects and specific histone acetylation and DNA methylation profiles in the mouse medial prefrontal cortex, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 82, p. 1, DOI: 10.1016/j.pnpbp.2017.12.009", "listPosition" : 134, "doi" : "10.1016/j.pnpbp.2017.12.009", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192033, "link" : "/api/reference/3192033", "label" : "135. Moretti 2020: rTMS-induced changes in Glutamatergic and dopaminergic systems: relevance to cocaine and Methamphetamine use disorders, Front. Neurosci., 14, p. 137, DOI: 10.3389/fnins.2020.00137", "listPosition" : 135, "doi" : "10.3389/fnins.2020.00137", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192034, "link" : "/api/reference/3192034", "label" : "136. Orson 2014: The future potential for cocaine vaccines, Expert. Opin. Biol. Ther., 14, p. 1271, DOI: 10.1517/14712598.2014.920319", "listPosition" : 136, "doi" : "10.1517/14712598.2014.920319", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192035, "link" : "/api/reference/3192035", "label" : "137. Lape 2010: A molecular model for cocaine binding by the immunotherapeutic human/mouse chimeric monoclonal antibody 2E2, Eur. J. Med. Chem., 45, p. 2291, DOI: 10.1016/j.ejmech.2010.02.004", "listPosition" : 137, "doi" : "10.1016/j.ejmech.2010.02.004", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192036, "link" : "/api/reference/3192036", "label" : "138. Harris 2015: Correction: the anti-(+)-Methamphetamine monoclonal antibody mAb7F9 attenuates acute (+)-Methamphetamine effects on intracranial self-stimulation in rats, PLoS One, 10, DOI: 10.1371/journal.pone.0138959", "listPosition" : 138, "doi" : "10.1371/journal.pone.0138959", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192037, "link" : "/api/reference/3192037", "label" : "139. Pettorruso 2019: rTMS stimulation group. rTMS Reduces psychopathological burden and cocaine consumption in treatment-seeking subjects with cocaine use disorder: An open label, Feasibility Study, Front Psychiatry, 10, p. 621, DOI: 10.3389/fpsyt.2019.00621", "listPosition" : 139, "doi" : "10.3389/fpsyt.2019.00621", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192038, "link" : "/api/reference/3192038", "label" : "140. Ma 2019: Effects of non-invasive brain stimulation on stimulant craving in users of cocaine, amphetamine, or methamphetamine: a systematic review and meta-analysis, Front. Neurosci., 13, p. 1095, DOI: 10.3389/fnins.2019.01095", "listPosition" : 140, "doi" : "10.3389/fnins.2019.01095", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192039, "link" : "/api/reference/3192039", "label" : "141. Brown 1990: Neurodynamics of relapse prevention: a neuronutrient approach to outpatient DUI offenders, J. Psychoactive Drugs, 22, p. 173, DOI: 10.1080/02791072.1990.10472542", "listPosition" : 141, "doi" : "10.1080/02791072.1990.10472542", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192040, "link" : "/api/reference/3192040", "label" : "142. Blum 2010: Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D₂ agonist therapy: part 2, Postgrad. Med., 122, p. 214, DOI: 10.3810/pgm.2010.11.2237", "listPosition" : 142, "doi" : "10.3810/pgm.2010.11.2237", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192041, "link" : "/api/reference/3192041", "label" : "143. Blum 1988: Reduction of both drug hunger and withdrawal against advice rate of cocaine abusers in a 30-day in-patient treatment program by the neuronutrient Tropamine, Curr. Ther. Res., 43, p. 1204", "listPosition" : 143, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192042, "link" : "/api/reference/3192042", "label" : "144. Cold 1996: NeuRecover-SATM in the treatment of cocaine withdrawal and craving: a pilot study, Clin Drug Investig., 12, p. 1, DOI: 10.2165/00044011-199612010-00001", "listPosition" : 144, "doi" : "10.2165/00044011-199612010-00001", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192043, "link" : "/api/reference/3192043", "label" : "145. Solanki 2020: Administration of a putative pro-dopamine regulator, a neuronutrient, mitigates alcohol intake in alcohol-preferring rats, Behav. Brain Res., 385, p. 112563, DOI: 10.1016/j.bbr.2020.112563", "listPosition" : 145, "doi" : "10.1016/j.bbr.2020.112563", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 3192044, "link" : "/api/reference/3192044", "label" : "146. Blum 2018: Pro-dopamine regulator (KB220) a fifty year sojourn to combat reward deficiency syndrome (RDS): evidence based bibliography (annotated), CPQ Neurol. Psycol., 1, p. 01", "listPosition" : 146, "published" : false, "snippet" : true } ], "hasCitationDuplums" : false, "userChangeableUntil" : "2021-04-22T10:04:12.853+0000", "directInstitutesForSort" : "", "ownerAuthorCount" : 12, "ownerInstituteCount" : 37, "directInstituteCount" : 0, "authorCount" : 3, "contributorCount" : 0, "hasQualityFactor" : true, "link" : "/api/publication/31823796", "label" : "Blum Kenneth et al. Psychostimulant use disorder emphasizing methamphetamine and the opioid -dopamine connection: Digging out of a hypodopaminergic ditch. (2021) JOURNAL OF THE NEUROLOGICAL SCIENCES 0022-510X 1878-5883 420", "template" : "